Evidence map›Paper›PMID 32352476›Full record

ArticleGenetics and molecular biology2020

A comparison between SOLiD 5500XLand Ion Torrent PGM-derived miRNA expression profiles in two breast cell lines.

Gabriela Pereira Branco, Renan Valieris, Lucas Venezian Povoa, Luiza Ferreira de Araújo, Gustavo Ribeiro Fernandes, Jorge Estefano Santana de Souza, Maria Galli de Amorim, Elisa Napolitano E Ferreira, Israel Tojal da Silva, Diana Noronha Nunes and 1 more

Open access · goldAbstract read
In one paragraph

Article in Genetics and molecular biology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 63% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Gabriela Pereira BrancoA.C.Camargo Cancer Center, Laboratório de Genômica Médica, CIPE, São Paulo, SP, Brazil.ORCID http://orcid.org/0000-0002-3120-4116
Renan ValierisA.C.Camargo Cancer Center, Laboratório de Biologia Computacional, São Paulo, SP, Brazil.ORCID http://orcid.org/0000-0002-8402-3175
Lucas Venezian PovoaA.C.Camargo Cancer Center, Laboratório de Biologia Computacional, São Paulo, SP, Brazil.
Luiza Ferreira de AraújoA.C.Camargo Cancer Center, Laboratório de Genômica Médica, CIPE, São Paulo, SP, Brazil.
Gustavo Ribeiro FernandesA.C.Camargo Cancer Center, Laboratório de Genômica Médica, CIPE, São Paulo, SP, Brazil.
Jorge Estefano Santana de SouzaUniversidade Federal do Rio Grande do Norte, Instituto Metrópole Digital, Natal, RN, Brazil.
Maria Galli de AmorimA.C.Camargo Cancer Center, Laboratório de Genômica Médica, CIPE, São Paulo, SP, Brazil.
Elisa Napolitano E FerreiraA.C.Camargo Cancer Center, Laboratório de Genômica e Biologia, CIPE, São Paulo, SP, Brazil.
Israel Tojal da SilvaA.C.Camargo Cancer Center, Laboratório de Biologia Computacional, São Paulo, SP, Brazil.ORCID http://orcid.org/0000-0002-4687-1499
Diana Noronha NunesA.C.Camargo Cancer Center, Laboratório de Genômica Médica, CIPE, São Paulo, SP, Brazil.ORCID http://orcid.org/0000-0003-0751-4701
Emmanuel Dias-NetoA.C.Camargo Cancer Center, Laboratório de Genômica Médica, CIPE, São Paulo, SP, Brazil.ORCID http://orcid.org/0000-0001-5670-8559
AC Camargo Hospital · BRFederal Institute of São Paulo · BRInstituto Federal do Rio Grande do Norte · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Next-generation sequencing (NGS) platforms allow the analysis of hundreds of millions of molecules in a single sequencing run, revolutionizing many research areas. NGS-based microRNA studies enable expression quantification in unprecedented scale without the limitations of closed-platforms. Yet, whereas a massive amount of data produced by these platforms is available, comparisons of quantification/discovery capabilities between platforms are still lacking. Here we compare two NGS-platforms: SOLiD and PGM, by evaluating their microRNA identification/quantification capabilities using two breast-derived cell-lines. A high expression correlation (R2 > 0.9) was achieved, encompassing 97% of the miRNAs, and the few discrepancies in miRNA counts were attributable to molecules that have very low expression. Quantification divergences indicative of artefactual representation were seen for 14 miRNAs (higher in SOLiD-reads) and another 10 miRNAs more abundant in PGM-data. An inspection of these revealed an increased and statistically significant count of uracyls and uracyl-stretches for PGM-enriched miRNAs, compared to SOLiD and to the miRBase. In parallel, adenines and adenine-stretches were enriched for SOLiDderived miRNA reads. We conclude that, whereas both platforms are overall consistent and can be used interchangeably for microRNA expression studies, particular sequence features appear to be indicative of specific platform bias, and their presence in microRNAs should be considered for database-analyses.

Identifiers

PMID32352476
PMCPMC7201575
OpenAlexW3022884556

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.